Association of Macrophage Migration Inhibitory Factor Gene –173 G/C Polymorphism (rs755622) with Familial Mediterranean Fever in Children

Abstract

Objectives The aim of this study was to identify the genotypic analysis and allele frequencies of the –173 G/C polymorphism in the macrophage migration inhibitory factor (MIF) gene in children diagnosed with familial Mediterranean fever (FMF).

Methods The study included 98 children who were diagnosed with FMF according to the Tel Hashomer criteria and one hundred and 57 healthy children as the control group. Genotyping was done for a polymorphism in a promoter region of the MIF gene (G/C at position –173).

Results The relationship of FMF prevalence and –173 G/C genotype of the MIF gene was statistically significant. Individuals with the CC genotype seem to be predisposed to FMF.

Conclusion The C/C polymorphism at position –173 of the MIF gene could be associated with excessive inflammation and immune response and can lead to susceptibility to FMF

Keywords

familial Mediterranean fever - disease severity score - macrophage migration inhibitory factor - gene polymorphism

Ethical Approval

The study was approved by the Gaziosmanpasa University Clinical Research Ethics Committee (ref. no.: 12-GOKAEK-011). All procedures were conducted after written informed consent was obtained from patients or guardians.

Publication History

Received: 27 April 2020

Accepted: 18 September 2020

Article published online:
25 November 2020

• References

• 1 Padeh S. Periodic fever syndromes. Pediatr Clin North Am 2005; 52 (02) 577-609 , vii
• 2 Ben-Chetrit E, Touitou I. Familial mediterranean fever in the world. Arthritis Rheum 2009; 61 (10) 1447-1453
• 3 Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967; 43 (02) 227-253
• 4 Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998; 351 (9103): 659-664
• 5 Yilmaz R, Ozer S, Ozyurt H, Erkorkmaz U, Sahin S. Familial Mediterranean fever gene mutations in the inner northern region of Turkey and genotype-phenotype correlation in children. J Paediatr Child Health 2009; 45 (11) 641-645
• 6 Pras M. Familial Mediterranean fever: from the clinical syndrome to the cloning of the pyrin gene. Scand J Rheumatol 1998; 27 (02) 92-97
• 7 Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 2002; 4 (04) 449-460
• 8 Flaster H, Bernhagen J, Calandra T, Bucala R. The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity. Mol Endocrinol 2007; 21 (06) 1267-1280
• 9 Kang I, Bucala R. The immunobiology of MIF: function, genetics and prospects for precision medicine. Nat Rev Rheumatol 2019; 15 (07) 427-437
• 10 Harris J, VanPatten S, Deen NS, Al-Abed Y, Morand EF. Rediscovering MIF: new tricks for an old cytokine. Trends Immunol 2019; 40 (05) 447-462
• 11 Leech M, Lacey D, Xue JR. et al. Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. Arthritis Rheum 2003; 48 (07) 1881-1889
• 12 Morand EF, Leech M, Weedon H, Metz C, Bucala R, Smith MD. Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations. Rheumatology (Oxford) 2002; 41 (05) 558-562
• 13 Illescas O, Gomez-Verjan JC, García-Velázquez L, Govezensky T, Rodriguez-Sosa M. Macrophage migration inhibitory factor-173 G/C polymorphism: a global meta-analysis across the disease spectrum. Front Genet 2018; 9: 55
• 14 Donn RP, Plant D, Jury F. et al. Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. J Invest Dermatol 2004; 123 (03) 484-487
• 15 Nohara H, Okayama N, Inoue N. et al. Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J Gastroenterol 2004; 39 (03) 242-246
• 16 Wang F-F, Huang X-F, Shen N. et al. A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease. Arthritis Res Ther 2013; 15 (03) R65
• 17 Santoscoy-Ascencio G, Baños-Hernández CJ, Navarro-Zarza JE. et al. Macrophage migration inhibitory factor promoter polymorphisms are associated with disease activity in rheumatoid arthritis patients from Southern Mexico. Mol Genet Genomic Med 2020; 8 (01) e1037
• 18 Bilsborrow JB, Doherty E, Tilstam PV, Bucala R. Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus. Expert Opin Ther Targets 2019; 23 (09) 733-744
• 19 Zheng X, Wang D, Hou S. et al. Association of macrophage migration inhibitory factor gene polymorphisms with Behçet's disease in a Han Chinese population. Ophthalmology 2012; 119 (12) 2514-2518
• 20 Pras M, Kastner DL. Familial Mediterranean fever. In: Klippel JH, Dieppe PA. eds. Rheumatology. 2nd ed. London: Mosby; 2000: 1-4
• 21 Gürel Ç, İnanır A, Nursal AF, Tekcan A, Rüstemoğlu A, Yigit S. Evaluation of MIF -173 G/C polymorphism in Turkish patients with ankylosing spondylitis. Balkan Med J 2016; 33 (06) 614-619
• 22 Makhija R, Kingsnorth A, Demaine A. Gene polymorphisms of the macrophage migration inhibitory factor and acute pancreatitis. JOP 2007; 8 (03) 289-295
• 23 Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005; 17 (05) 586-599
• 24 Touitou I, Lesage S, McDermott M. et al. Infevers: an evolving mutation database for auto-inflammatory syndromes. Hum Mutat 2004; 24 (03) 194-198
• 25 Dundar M, Kiraz A, Balta B. et al. The role of TNF-α and PAI-1 gene polymorphisms in familial Mediterranean fever. Mod Rheumatol 2013; 23 (01) 140-145
• 26 Popa C, van Lieshout AW, Roelofs MF. et al. MIF production by dendritic cells is differentially regulated by Toll-like receptors and increased during rheumatoid arthritis. Cytokine 2006; 36 (1-2): 51-56
• 27 Onodera S, Nishihira J, Koyama Y. et al. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1β. Arthritis Rheum 2004; 50 (05) 1437-1447
• 28 Sampey AV, Hall PH, Mitchell RA, Metz CN, Morand EF. Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor. Arthritis Rheum 2001; 44 (06) 1273-1280
• 29 Denkinger CM, Metz C, Fingerle-Rowson G, Denkinger MD, Forsthuber T. Macrophage migration inhibitory factor and its role in autoimmune diseases. Arch Immunol Ther Exp (Warsz) 2004; 52 (06) 389-400
• 30 Kasama T, Ohtsuka K, Sato M, Takahashi R, Wakabayashi K, Kobayashi K. Macrophage migration inhibitory factor: a multifunctional cytokine in rheumatic diseases. Arthritis (Egypt) 2010; 2010: 106202
• 31 Donn RP, Shelley E, Ollier WE, Thomson W. British Paediatric Rheumatology Study Group. A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001; 44 (08) 1782-1785
• 32 Yildiz G, Kayatas M, Uygun Y, Timuçin M, Candan F. Coexistence of systemic lupus erythematosus and familial Mediterranean fever. Intern Med 2010; 49 (08) 767-769
• 33 Aksu K, Keser G. Coexistence of vasculitides with familial Mediterranean fever. Rheumatol Int 2011; 31 (10) 1263-1274
• 34 Ergul AB, Dursun I, Torun YA. Hashimoto's thyroiditis in a child with familial mediterranean fever: a case report. Iran J Pediatr 2013; 23 (04) 489-490
• 35 Erten S, Taskaldiran I, Yakut ZI. Are systemic lupus erythematosus patients carrying MEFV gene less prone to renal involvement? Report of three cases and review of the literature. Ren Fail 2013; 35 (07) 1013-1016
• 36 Renner P, Roger T, Calandra T. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin Infect Dis 2005; 41 (Suppl. 07) S513-S519
• 37 Donn R, Alourfi Z, Zeggini E. British Paediatric Rheumatology Study Group. et al. A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum 2004; 50 (05) 1604-1610
• 38 Pakozdi A, Amin MA, Haas CS. et al. Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis. Arthritis Res Ther 2006; 8 (04) R132
• 39 Martínez A, Orozco G, Varadé J. et al. Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility. Hum Immunol 2007; 68 (09) 744-747
• 40 Liu R, Xu N, Wang X. et al. Influence of MIF, CD40, and CD226 polymorphisms on risk of rheumatoid arthritis. Mol Biol Rep 2012; 39 (06) 6915-6922
• 41 De Benedetti F, Meazza C, Vivarelli M. British Paediatric Rheumatology Study Group. et al. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2003; 48 (05) 1398-1407
• 42 Sánchez E, Gómez LM, Lopez-Nevot MA. et al. Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus. Genes Immun 2006; 7 (05) 433-436
• 43 Rigante D, Flex A, Federico G. et al. Serum macrophage migration inhibitory factor (MIF) in the intercritical phase of hereditary periodic fevers and its relationship with the MIF-173G/C polymorphism. Scand J Rheumatol 2007; 36 (04) 307-310
• 44 Çakmak E, Ece A, Kelekçi S, Yolbaş İ, Güneş A, Şen V. Comparison of acute phase response during attack and attack-free period in children with familial Mediterranean Fever. J Clin Exp Invest 2013; 4: 231-18
• 45 Özer S, Yılmaz R, Sönmezgöz E. et al. Simple markers for subclinical inflammation in patients with familial Mediterranean fever. Med Sci Monit 2015; 21: 298-303
• 46 Llamas-Covarrubias MA, Valle Y, Navarro-Hernández RE. et al. Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course. Rheumatol Int 2012; 32 (08) 2307-2311
• 47 Dambacher J, Staudinger T, Seiderer J. et al. Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease. Inflamm Bowel Dis 2007; 13 (01) 71-82
• 48 Assis DN, Takahashi H, Leng L, Zeniya M, Boyer JL, Bucala R. A macrophage migration inhibitory factor polymorphism is associated with autoimmune hepatitis severity in US and Japanese patients. Dig Dis Sci 2016; 61 (12) 3506-3512
• 49 Barton A, Lamb R, Symmons D. et al. Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun 2003; 4 (07) 487-491
• 50 Radstake TR, Sweep FC, Welsing P. et al. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 2005; 52 (10) 3020-3029
• 51 Baugh JA, Chitnis S, Donnelly SC. et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002; 3 (03) 170-176
• 52 Yao J, Leng L, Sauler M. et al. Transcription factor ICBP90 regulates the MIF promoter and immune susceptibility locus. J Clin Invest 2016; 126 (02) 732-744
• 53 De la Cruz-Mosso U, Bucala R, Palafox-Sánchez CA. et al. Macrophage migration inhibitory factor: association of -794 CATT5-8 and -173 G>C polymorphisms with TNF-α in systemic lupus erythematosus. Hum Immunol 2014; 75 (05) 433-439
• 54 Morales-Zambrano R, Bautista-Herrera LA, De la Cruz-Mosso U. et al. Macrophage migration inhibitory factor (MIF) promoter polymorphisms (-794 CATT5-8 and -173 G>C): association with MIF and TNFα in psoriatic arthritis. Int J Clin Exp Med 2014; 7 (09) 2605-2614
• 55 Sreih AG, Ezzedine R, Leng L. et al. Role of macrophage migration inhibitory factor in granulomatosis with polyangiitis. Arthritis Rheumatol 2018; 70 (12) 2077-2086